Jiyoun Park
Medical · Decatur, GANPI 1497146351
Payments from drug & device makers
Across 137 payments — averaging $24.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$789
- Amgen$535
- E.r. Squibb & Sons, L.L.C.$373
- Pfizer$263
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$206
- Vital Connect, Inc$183
- plus $1K from 16 others
What the payments were for
- Consulting fees$75022%
- Food & beverage$2,65978%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 7 | $789 |
| Amgen | 17 | $535 |
| E.r. Squibb & Sons, L.L.C. | 20 | $373 |
| Pfizer | 14 | $263 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $206 |
| Vital Connect, Inc | 13 | $183 |
| Johnson & Johnson | 12 | $170 |
| AstraZeneca | 8 | $146 |
| Merck | 8 | $145 |
| Novo Nordisk | 7 | $134 |
| Novartis | 6 | $102 |
| Boehringer Ingelheim | 5 | $99 |
| Boston Scientific | 3 | $59 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Edwards Lifesciences | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Convatec Inc. | 1 | $21 |
| United Therapeutics Corporation | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,424 in reported general payments places this provider in the 75th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $5,974 |
| ClopidogrelClopidogrel Bisulfate | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $263 | $5,97411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 950 medical providers in Georgia.
Other medical in Decatur
- Rhea DouglasDecatur$13K
- Amanda SandersDecatur$11K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.